Aclarion announces non-convertible debt financing to achieve three critical catalysts

Up to $2m unsecured, non-convertible bridge debt with no required amortization payments financing supports execution of the 2023 plan and the achievement of critical milestones in support of definitive growth capital broomfield, co, may 19, 2023 (globe newswire) -- via newmediawire – aclarion, inc., (“aclarion” or the “company”) (nasdaq: acon, aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today the closing of up to a $2m unsecured, non-convertible debt financing that allows the company to continue executing on its 2023 plan while providing the runway to achieve three critical milestones ahead of securing definitive growth capital. brent ness, ceo of aclarion, said, “we have been executing really well on multiple fronts.
ACON Ratings Summary
ACON Quant Ranking